Intelligence · Clinical Pipeline
Compass Therapeutics Pipeline
All ClinicalTrials.gov programs at Compass Therapeutics — phase, modality, and trial IDs.
- Programs
- 8
Quick answer
Compass Therapeutics has 8 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
CTX-009
Compass Therapeutics
Glioblastoma
1 trial -
CTX-009
Compass Therapeutics
Metastatic Colorectal Cancer
1 trial -
CTX-009 (ABL001)
Compass Therapeutics
P1b: Advanced Solid Tumors
1 trial -
Gemcitabine
Compass Therapeutics
Metastatic Biliary Tract Cancer
1 trial -
Psilocybin
Compass Therapeutics
Treatment-Resistant Major Depressive Disorder
1 trial -
Psilocybin
Compass Therapeutics
Anorexia Nervosa
2 trials -
Psilocybin
Compass Therapeutics
Body Dysmorphic Disorders
1 trial -
Psilocybin
Compass Therapeutics
Post Traumatic Stress Disorder
1 trial
Frequently asked questions
How many pipeline programs does Compass Therapeutics have?
8 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs